The Discounted Cash Flow (DCF) valuation of Generex Biotechnology Corp (GNBT) is (0.11) USD. With the latest stock price at 0.00 USD, the upside of Generex Biotechnology Corp based on DCF is -56662.3%.
Based on the latest price of 0.00 USD and our DCF valuation, Generex Biotechnology Corp (GNBT) is a sell. selling GNBT stocks now will result in a potential gain of 56662.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 3.8% - 6.4% | 5.1% |
| Long-term Growth Rate | 3.0% - 3.6% | 3.3% |
| Fair Price | (0.70) - (0.07) | (0.11) |
| Upside | -349591.9% - -35313.2% | -56662.3% |